Liver disease in children with cystic fibrosis: A sono-biochemical comparision in 195 patients

Paediatric Respiratory Reviews

Volumn 2, Issue 4, 2001, Pages 340-349

  Patriquin, H ^a   Perreault, G ^a   Grignon, A ^a   Filiatrault, D ^a   Boisvert, J ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Biliary tract diseases; Cholagogues and choleretics; Cholestasis; Cystic fibrosis; Liver; Liver diseases; Portal hypertension; Transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALCOHOL; ALKALINE PHOSPHATASE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BICARBONATE; BILE ACID; BILIRUBIN; CALCIUM; CHLORIDE; CHLORIDE ION; CHOLESTEROL; CHONDROITIN SULFATE; COLCHICINE; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTOCOMPATIBILITY ANTIGEN; INTERFERON; LIVER ENZYME; MEMBRANE PROTEIN; NUCLEOTIDE; PROTEIN; PURINE DERIVATIVE; REGULATOR PROTEIN; STEROID; TRANSFERASE; UNINDEXED DRUG; URSODEOXYCHOLIC ACID;

ADOLESCENT; ARTICLE; CHILD; CHOLECYSTITIS; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE MARKER; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; HUMAN TISSUE; LIFE EXPECTANCY; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; ONSET AGE; PATHOGENESIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PUBERTY; SCREENING TEST; STEATOSIS; ULTRASOUND; VISCOSITY;

EID: 0035737827     PISSN: 15260550     EISSN: None     Source Type: Journal    
DOI: 10.1053/prrv.2001.0170     Document Type: Article

References (24)

1. Cystic Fibrosis Foundation, Patient Registry 1996
2. Recommendations for management of liver and biliary tract disease in cystic fibrosis
3. Prevalence of liver disease in cystic fibrosis
4. Liver disease and common bile duct stenosis in cystic fibrosis
5. Analysis of the risk factors for the development of liver disease associated with cystic fibrosis
6. The evolution of liver disease in cystic fibrosis
7. Liver involvement in cystic fibrosis
8. Bile acid therapy in paediatric hepatobiliary disease: The role of ursodeoxycholic acid
9. Severe liver disease in cystic fibrosis is associated with heterozygosity for mutations in alpha-one antitrypsin protease inhibitor gene
10. Good care for people with cystic fibrosis
11. Liver disease in children with cystic fibrosis: US-biochemical comparison in 195 patients
12. An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis
13. Does ursodeoxycholic acid improve histological changes in liver disease in cystic fibrosis?
14. Can the histologic changes of cystic fibrosis associated hepatobiliary disease be predicted by clinical criteria?
15. Ursodeoxycholic acid for cystic fibrosis-related liver disease
16. Use of ursodeoxycholic acid in liver diseases
17. Ursodeoxycholic acid for primary biliary cirrhosis
18. Outcome of cystic fibrosis-associated liver cirrhosis: Management of portal hypertension
19. Liver transplantation for hepatic cirrhosis in cystic fibrosis
20. Liver transplantation for hepatic cirrhosis in cystic fibrosis
21. Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary fibrosis
22. Pediatric liver transplantation for cystic fibrosis
23. Health related quality of life after liver transplantation: A meta-analysis
24. Long term nutritional and neurodevelopmental outcome of liver transplantation in infants aged less than 12 months